Life sciences innovation is a critical growth engine, with regions worldwide competing to turn scientific discovery into global impact. While legacy leaders dominate, emerging ecosystems are shaping new models to accelerate progress. Global leaders like Boston, the Bay Area and the UK continue to set the pace, but rising hubs across Asia and the Middle East are quickly gaining ground.
Our benchmark reveals how ecosystems succeed across funding, talent and commercialization — and what emerging markets must do to compete globally.
Methodology
L.E.K. Consulting assessed six leading and rising ecosystems (the Bay Area, Boston, the UK Golden Triangle, Shanghai, Singapore and South Korea) across five pillars:
- Public funding: Public capital that de-risks early innovation
- Capital markets: Clear exit pathways and diverse investor bases
- Operational enablers: Streamlined regulation and advanced infrastructure
- Human & network capital: Experienced talent and cross-sector collaboration
- Commercial: Market scale and integration into global demand